NEXUS BIOPHARMA INC Retained Earnings
NEXUS BIOPHARMA INC had Retained Earnings of -$3.68 million as of 2017-05-31, per its 10-Q filed 2017-10-27.
Discontinued › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2017-10-27
- 2017-05-31: Retained Earnings (Accumulated Deficit) -$3.68M.
- 2017-02-28: Retained Earnings (Accumulated Deficit) -$3.29M.
- 2016-11-30: Retained Earnings (Accumulated Deficit) -$3.19M.
- 2016-08-31: Retained Earnings (Accumulated Deficit) -$3.05M.
| Period end | Retained Earnings (Accumulated Deficit) |
|---|---|
| 2017-05-31 | -$3.68M 10-Q · filed 2017-10-27 |
| 2017-02-28 | -$3.29M 10-Q · filed 2017-10-27 |
| 2016-11-30 | -$3.19M 10-Q · filed 2017-04-10 |
| 2016-08-31 | -$3.05M 10-Q · filed 2016-10-24 |
| 2016-03-31 | -$198.42K 10-Q · filed 2016-05-10 |
| 2016-02-29 | -$2.61M 10-K · filed 2017-07-05 |
| 2015-12-31 | -$191.12K 10-Q · filed 2016-05-10 |
| 2015-09-30 | -$187.57K 10-Q · filed 2015-11-12 |
| 2015-06-30 | -$184.49K 10-Q · filed 2015-08-13 |
| 2015-03-31 | -$169.44K 10-Q · filed 2015-05-06 |
| 2014-12-31 | -$149.27K 10-K · filed 2016-03-28 |
| 2014-09-30 | -$149.27K 10-Q · filed 2015-04-20 |
| 2014-06-30 | -$149.27K 10-Q · filed 2015-04-20 |
| 2014-03-31 | -$147.87K 10-Q · filed 2015-04-09 |
| 2013-12-31 | -$147.87K 10-Q · filed 2015-04-20 |
| 2013-09-30 | -$147.87K 10-Q · filed 2015-02-24 |
| 2013-06-30 | -$143.57K 10-Q · filed 2013-08-14 |
| 2013-03-31 | -$140.74K 10-Q · filed 2013-05-20 |
| 2012-12-31 | -$132.61K 10-K · filed 2015-04-02 |
| 2012-09-30 | -$135.01K 10-Q · filed 2012-11-19 |
| 2012-06-30 | -$131.35K 10-Q/A · filed 2012-10-02 |
| 2012-03-31 | -$127.81K 10-Q · filed 2012-04-24 |
| 2011-12-31 | -$123.23K 10-K · filed 2013-04-15 |
| 2011-09-30 | -$119.98K 10-Q · filed 2011-11-14 |
| 2011-06-30 | -$116.80K 10-Q · filed 2011-07-26 |
| 2010-12-31 | -$107.91K 10-K · filed 2012-03-29 |